Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ingelman-Sundberg

Showing results (231-240 of 278) with videos related to

Pageof 28
Sort By:
The Pharmacogenomics Journal|February 25, 2015
Pharmacogenomic information in drug labels: European Medicines Agency perspectiveF Ehmann, L Caneva, K Prasad, et al.
EXS|January 1, 1994
Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicityM Ingelman-Sundberg, I Johansson, I Persson, et al.
Carcinogenesis|March 1, 1990
Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymesH Wallin, A Mikalsen, F P Guengerich, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugsS W French, R J Mayer, F Bardag-Gorce, et al.
Molecular Pharmacology|April 16, 2003
Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gammaC Rodríguez-Antona, R Bort, R Jover, et al.
The Pharmacogenomics Journal|October 10, 2007
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolismC Rodríguez-Antona, M Niemi, J T Backman, et al.
Lancet (London, England)|January 2, 1993
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineL Bertilsson, M L Dahl, F Sjöqvist, et al.
Biochemical and Biophysical Research Communications|December 9, 2000
The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcoholF Bardag-Gorce, Q X Yuan, J Li, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Polymorphic 2-hydroxylation of desipramine. A population and family studyM L Dahl, L Iselius, C Alm, et al.
International Journal of Cancer|February 1, 1993
Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cellsM Houde, G de Bruyne, M Bracke, et al.
Pageof 28

Showing results (231-240 of 278) with videos related to

Sort By:
Pageof 28
The Pharmacogenomics Journal|February 25, 2015
Pharmacogenomic information in drug labels: European Medicines Agency perspectiveF Ehmann, L Caneva, K Prasad, et al.
EXS|January 1, 1994
Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicityM Ingelman-Sundberg, I Johansson, I Persson, et al.
Carcinogenesis|March 1, 1990
Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymesH Wallin, A Mikalsen, F P Guengerich, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugsS W French, R J Mayer, F Bardag-Gorce, et al.
Molecular Pharmacology|April 16, 2003
Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gammaC Rodríguez-Antona, R Bort, R Jover, et al.
The Pharmacogenomics Journal|October 10, 2007
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolismC Rodríguez-Antona, M Niemi, J T Backman, et al.
Lancet (London, England)|January 2, 1993
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineL Bertilsson, M L Dahl, F Sjöqvist, et al.
Biochemical and Biophysical Research Communications|December 9, 2000
The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcoholF Bardag-Gorce, Q X Yuan, J Li, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Polymorphic 2-hydroxylation of desipramine. A population and family studyM L Dahl, L Iselius, C Alm, et al.
International Journal of Cancer|February 1, 1993
Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cellsM Houde, G de Bruyne, M Bracke, et al.
Pageof 28